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background: Recent studies have demonstrated that deteriorating renal function was associated with increased coronary plaque burden. The aim 
was to investigate coronary atherosclerotic plaque change in non-culprit lesions using IVUS and integrated backscatter IVUS (IB-IVUS).
Methods: We investigated 80 non-culprit lesions undergoing both IVUS-guided percutaneous coronary intervention (PCI) and follow-up IVUS. 
According to baseline estimated glomerular filtration rate (eGFR), patients were divided into 3 groups (group-1; eGFR ≥ 60 ml/min/1.73m2, 
43 lesions, group-2; 60 > eGFR > 15 ml/min/1.73m2, 26 lesions, and group-3; under hemodialysis (eGFR < 15 ml/min/1.73m2), 11 lesions. 
Volumetric IVUS analyses were performed at proximal non-culprit lesions in de novo target vessels post PCI and at 6-12 months follow-up. All 
patients were managed with careful medical treatment during follow-up. We compared serial change in non-culprit coronary atherosclerotic plaque 
burden and composition among groups.
results: Plaque volume at baseline was similar among groups (35 mm3 in group-1, and 37 mm3 in group-2, 42 mm3 in group-3, p = 0.30). 
At follow-up, however, plaque volume significantly increased in group-2 (+ 2.7 mm3, p < 0.05) and group-3 (+ 9.8 mm3, p < 0.05), whereas it 
decreased in group-1 (- 3.0 mm3, p < 0.01). IB-IVUS analysis showed that lipid plaque increased in group-2 (+ 3.2 mm3, p < 0.01) and group-3 (+ 
4.8 mm3, p = 0.05), whereas it decreased in group-1 (- 2.1 mm3, p = 0.06) at follow-up. Fibrous plaque also increased in group-3 (+ 3.8 mm3, p < 
0.003), whereas it did not change in group-1 (- 1.3 mm3, p = 0.10) and group-2 (- 0.5 mm3, p = 0.57). Multiple linear regression analysis revealed 
CKD stage was an independent predictor of plaque progression (p < 0.001). Plaque changes in non-culprit lesions had no correlation with target 
lesion revascularization.
conclusions: Hemodialysis was associated with coronary atherosclerotic plaque progression composed of greater lipid and fibrosis in non-culprit 
lesions despite careful medical treatment after PCI. Strict risk management should be required to prevent coronary atherosclerosis progression of 
non-culprit lesions in hemodialysis patients.
